Evotec

Evotec sells Single Molecule Detection Technology and IP portfolio to Olympus

Published in Healthcare Mergers, Acquisitions and Ventures Week, August 26th, 2006

Evotec AG (EVT) announced that its Tools and Technologies Division (Evotec Technologies GmbH) has sold the core of its Single Molecule Detection Technology and transferred or licensed the corresponding IP portfolio to Olympus Corporation, Tokyo, Japan.

This transaction is a further step taken by Evotec Technologies to increasingly focus its business on providing cutting-edge cell imaging and cell handling systems for the cell biology growth market.

Over the past years Evotec Technologies has developed a set of innovative confocal detection methods for single molecule drug discovery. This Technology & IP portfolio and the related know-how will now be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2006-08-26)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Abaxis
Abaxis reports 43% increase in revenue
Abbott
Abbott reports earnings of $0.62 per share
Abt Associates
David Loeser named senior vice president of Abt Associates
Adams Respiratory Therapeutics
Adams Respiratory plans to repurchase manufacturing assets from Cardinal Health
Alcon
Alcon's second quarter sales rise 11.8%
Align Technology
Align Technology reports Q2 2006 revenues of $53.2 million
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry